← All patents

US20150250793A1

Bax agonist, compositions, and methods related thereto

University of Texas System

Abstract

To compare sensitivities of the compounds, A549 human lung cancer cells were treated with increasing concentrations (0, 1, 5, 10, 25 μM) of 2-(2-Nitro-fluoren-9-ylidenemethyl)-phenol (CYD-1-87) and derivatives for 48 h. The surviving cell fraction was determined using the sulforhodamine B (SRB) …

University
University of Texas System
Assignee
Board Of Regents Of The University Of Texas System
Inventor
Xingming Deng
Priority date
August 19, 2011
Filing date
May 12, 2015
Publication date
September 10, 2015
Language
en
Metadata fetched
August 29, 2026 00:23